company background image
4530 logo

Hisamitsu Pharmaceutical TSE:4530 Stock Report

Last Price

JP¥3.74k

Market Cap

JP¥276.1b

7D

-1.0%

1Y

5.6%

Updated

13 Jun, 2024

Data

Company Financials +

Hisamitsu Pharmaceutical Co., Inc.

TSE:4530 Stock Report

Market Cap: JP¥276.1b

Hisamitsu Pharmaceutical Co., Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Hisamitsu Pharmaceutical
Historical stock prices
Current Share PriceJP¥3,738.00
52 Week HighJP¥5,497.00
52 Week LowJP¥3,541.00
Beta0.39
1 Month Change-1.50%
3 Month Change-4.18%
1 Year Change5.56%
3 Year Change-35.33%
5 Year Change-16.00%
Change since IPO747.62%

Recent News & Updates

Why We're Not Concerned About Hisamitsu Pharmaceutical Co., Inc.'s (TSE:4530) Share Price

Apr 09
Why We're Not Concerned About Hisamitsu Pharmaceutical Co., Inc.'s (TSE:4530) Share Price

Here's Why We Think Hisamitsu Pharmaceutical (TSE:4530) Is Well Worth Watching

Mar 18
Here's Why We Think Hisamitsu Pharmaceutical (TSE:4530) Is Well Worth Watching

Recent updates

Why We're Not Concerned About Hisamitsu Pharmaceutical Co., Inc.'s (TSE:4530) Share Price

Apr 09
Why We're Not Concerned About Hisamitsu Pharmaceutical Co., Inc.'s (TSE:4530) Share Price

Here's Why We Think Hisamitsu Pharmaceutical (TSE:4530) Is Well Worth Watching

Mar 18
Here's Why We Think Hisamitsu Pharmaceutical (TSE:4530) Is Well Worth Watching

Shareholder Returns

4530JP PharmaceuticalsJP Market
7D-1.0%-0.7%0.3%
1Y5.6%-0.7%17.5%

Return vs Industry: 4530 exceeded the JP Pharmaceuticals industry which returned -0.7% over the past year.

Return vs Market: 4530 underperformed the JP Market which returned 17.5% over the past year.

Price Volatility

Is 4530's price volatile compared to industry and market?
4530 volatility
4530 Average Weekly Movement2.4%
Pharmaceuticals Industry Average Movement3.7%
Market Average Movement3.9%
10% most volatile stocks in JP Market7.5%
10% least volatile stocks in JP Market2.1%

Stable Share Price: 4530 has not had significant price volatility in the past 3 months.

Volatility Over Time: 4530's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
18472,759Kazuhide Nakatomiwww.hisamitsu.co.jp

Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals in Japan. The company provides external pain-relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; BUTENALOCK, a remedy for athlete's foot; and ALLEGRA FX, a sinus medication for allergies. It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, a transdermal analgesic anti-inflammatory drug; and patches for female hormone, asthma, and overactive bladders.

Hisamitsu Pharmaceutical Co., Inc. Fundamentals Summary

How do Hisamitsu Pharmaceutical's earnings and revenue compare to its market cap?
4530 fundamental statistics
Market capJP¥276.06b
Earnings (TTM)JP¥13.97b
Revenue (TTM)JP¥141.71b

19.6x

P/E Ratio

1.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4530 income statement (TTM)
RevenueJP¥141.71b
Cost of RevenueJP¥62.74b
Gross ProfitJP¥78.97b
Other ExpensesJP¥65.00b
EarningsJP¥13.97b

Last Reported Earnings

Feb 29, 2024

Next Earnings Date

Jul 11, 2024

Earnings per share (EPS)190.46
Gross Margin55.73%
Net Profit Margin9.86%
Debt/Equity Ratio0.4%

How did 4530 perform over the long term?

See historical performance and comparison

Dividends

2.3%

Current Dividend Yield

46%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.